Dashboard
Manage Tickers

AZN ASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 89.22 $ 1.05 (1.19 %)    

Tuesday, 11-Nov-2025 15:45:54 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 621.90 $ 1.31 (0.21 %)
DIA $ 479.63 $ 5.49 (1.16 %)
SPY $ 683.11 $ 3.13 (0.46 %)
TLT $ 89.96 $ 0.02 (0.03 %)
GLD $ 379.84 $ -0.17 (-0.04 %)
$ 87.48
$ 88.18
$ 89.22 x 111
$ 89.23 x 491
$ 88.00 - $ 89.26
$ 60.82 - $ 87.53
6,271,748
na
135.65B
$ 0.41
$ 7.49
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

astrazenecas-investigational-hypertension-drug-shows-significant-blood-pressure-control-in-pivotal-trial
AstraZeneca's Investigational Hypertension...
11/10/2025 18:39:23

AstraZeneca's Baxdrostat cut blood pressure by 14 mmHg in the Phase 3 Bax24 trial, showing strong efficacy and safety in re...

reported-earlier-astrazeneca-highlights-baxdrostats-140-mmhg-ambulatory-sbp-drop-and-139-mmhg-night-time-benefit-with-odds-ratio-152-for-target-achievement-at-week-12
Reported Earlier, AstraZeneca Highlights B...
11/10/2025 07:29:06

Baxdrostat demonstrated a statistically significant placebo-adjusted reduction of 13.9 mmHg in night-time ambulatory systolic b...

natron-phase-iii-trial-shwed-astrazenecas-fasenra-demonstrated-statistically-significant-delay-in-first-worsening-or-time-to-fare-in-hypereosinophilic-syndrome
NATRON Phase III Trial Shwed AstraZeneca's...
11/07/2025 14:01:47

eli-lilly-novo-nordisk-make-weight-loss-drugs-more-affordable-via-medicare-medicaid-trumprx
Eli Lilly, Novo Nordisk Make Weight-Loss D...
11/06/2025 19:10:21

The Trump administration struck deals with Eli Lilly and Novo Nordisk to lower obesity drug prices and expand Medicare coverage...

ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday
AI Stocks Slide Again, Bitcoin Dips Near $...
11/06/2025 17:45:11

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

astrazeneca-calms-pricing-jitters-says-us-deal-hit-absorbable
AstraZeneca Calms Pricing Jitters, Says US...
11/06/2025 15:04:09

AstraZeneca's Q3 sales rose 12% to $15.19 billion, beating forecasts as cancer and biopharma growth lifted results; 2025 gu...

Core News & Articles
Axsome Therapeutics Signs Deal To Acquire ...
11/06/2025 12:12:05

Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous syst...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

astrazeneca-q3-adj-eps-119-beats-114-estimate-sales-15191b-beat-14805b-estimate
AstraZeneca Q3 Adj. EPS $1.19 Beats $1.14 ...
11/06/2025 08:21:26

AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.14 by 4...

snowflake-and-sap-bridge-enterprise-data-silos-in-major-ai-integration-push
Snowflake And SAP Bridge Enterprise Data S...
11/04/2025 19:30:05

Snowflake Inc. & SAP SE collaborate to integrate their AI and business data clouds, providing faster access to reliable dat...

Core News & Articles
Governor Of Virginia Says Industry Partner...
10/31/2025 21:01:26

-Reuters

Core News & Articles
Reported Earlier, Daiichi Sankyo And Astra...
10/31/2025 07:53:48

astrazeneca-daiichi-sankyos-datroway-showed-statistically-significant-clinically-meaningful-improvement-for-dual-primary-endpoints-of-overall-survival-progression-free-survival-in-tropion-breast02-phase-3-study-for-recurrent-inoperable-or-metastatic-triple-negative-breast-cancer
AstraZeneca, Daiichi Sankyo's DATROWAY Sho...
10/29/2025 12:14:31

Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated a statis...

Core News & Articles
'US Fires Top Health Official Who Opposed ...
10/28/2025 12:50:58

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

eccogene-eyes-hong-kong-ipo-with-experimental-weight-loss-drug-astrazeneca-partnership
Eccogene Eyes Hong Kong IPO With Experimen...
10/23/2025 13:22:01

peering-into-astrazeneca-plcs-recent-short-interest
Peering Into AstraZeneca PLC's Recent Shor...
10/22/2025 14:00:51

the-european-agency-recommends-approving-astrazenecas-saphnelo-as-self-administered-once-weekly-pre-filled-pen-for-systemic-lupus-erythematosus-on-top-of-standard-therapy-8k
The European Agency Recommends Approving A...
10/20/2025 11:16:59

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on interi...

Core News & Articles
Reported Sunday, AstraZeneca And Daiichi S...
10/20/2025 07:36:33

AstraZeneca and Daiichi Sankyo's DATROWAY also demonstrated a highly statistically significant and clinically meaningful 43...

Core News & Articles
Amgen Announces FDA Approval Of TEZSPIRE F...
10/17/2025 20:02:05

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation

invo-fertility-stock-is-plunging-after-white-house-announcement
Invo Fertility Stock Is Plunging After Whi...
10/17/2025 18:37:05

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION